SFRP5 and metabolic dysfunction-associated steatohepatitis: This result is in accordance with a recent study in L02 hepatocytes in which inhibition of the PPARγ/SFRP5 pathway promoted the conversion of NAFL into NASH by activation of macrophage Kupffer cells [87].